Disclosures for "Safety, Tolerability, and Pharmacokinetics of Single and Multiple Rising Doses of a Next Generation Prodrug Troriluzole in Healthy Subjects"
-
Ms. Sevinsky has received personal compensation for serving as an employee of Biohaven. Ms. Sevinsky has stock in Biohaven.
-
Dr. Awsare has received personal compensation for serving as an employee of Biohaven. Dr. Awsare has stock in Biohaven.
-
Dr. Rozakis has nothing to disclose.
-
Kimberly Gentile has stock in Biohaven.
-
Ms. Mydlow has nothing to disclose.
-
Mr. Ashbrenner has received personal compensation for serving as an employee of Biohaven. Mr. Ashbrenner has received personal compensation for serving as an employee of Navitas. Mr. Ashbrenner has stock in Biohaven. An immediate family member of Mr. Ashbrenner has stock in Biohaven.
-
Ms. Ham has received personal compensation for serving as an employee of Allucent.
-
David Stock has received personal compensation for serving as an employee of Biohaven . David Stock has stock in Biohaven .
-
Dr. Qureshi has received personal compensation for serving as an employee of Biohaven.
-
Vladimir Coric has received personal compensation for serving as an employee of Biohaven. Vladimir Coric has received personal compensation in the range of $1,000,000+ for serving as an officer or member of the Board of Directors for Bioahven. Vladimir Coric has stock in Biohaven. Vladimir Coric has received intellectual property interests from a discovery or technology relating to health care.
-
Richard Bertz has received personal compensation for serving as an employee of Biohaven Pharmaceuticals. Richard Bertz has stock in Biohaven Pharmaceuticals.